If there's one thing an Olympic gold medalist can attest to, it's the fact that strength and conditioning are only half the battle when seeking a win; mental health and inner confidence are just as important. For gymnast Gabby Douglas, the pandemic was the perfect time to focus on both mental and physical well-being.
"Taking care of your physical and mental health is key. That's the new wealth," she said.
For young gymnasts and aspiring Olympians, especially, Douglas noted that confidence is the secret sauce to finding success and following dreams.
"I would say never limit your talent or your beliefs because of someone else's limited imagination. If you have a passion, heart, to do something, then go for it 100 percent," she added.
The gold medalist recently expanded her non-athletic professional portfolio by partnering with Smoothie King to promote a new line of drinks aimed at boosting health.
"I try to incorporate smoothies every single day with post-workout [drinks], and even when I start my day, because they have such amazing benefits with fuel, with brain function, and, like you said, overall joint health. And just the recovery, the muscle recovery, is beyond," Douglas told Cheddar.
Smoothie King's new line of Stretch & Flex Smoothies are available in two flavors, Tart Cherry and Pineapple Kale, and include a "proprietary blend" of type II collagen according to the company.
Burger King is closing two dozens locations in the Detroit area and laying off 424 employees as it plans to permanently cease operations in Michigan. The Texas-based burger chain blamed "unforeseen business circumstances." The closures started on March 17 and are expected to be finished by April 15.
Minnesota Attorney General Keith Ellison is slated to lead off opening statements expected for Tuesday in his state's lawsuit against Juul Labs – marking the first time any of the thousands of cases against the e-cigarette maker over its alleged marketing to young people is going to play out in a courtroom.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
